Intrommune Therapeutics

Intrommune is a New York City-based biotechnology company dedicated to streamlining allergy immunotherapy.Intrommune’s core technology enables the delivery of immunotherapeutic agents in a specially formulated toothpaste designed to incorporate and stabilize allergenic proteins, representing a novel treatment approach for peanut and other food allergies.Allergy immunotherapy via brushing is referred to as Oral Mucosal Immunotherapy (OMIT). OMIT delivers sensitizing proteins to the oral cavity, potentially prompting the immune system to develop tolerance without allergen ingestion. OMIT could address a significant healthcare need in the industrialized world, where the spread of food allergies has been characterized as an "epidemic."Intrommune's mission is to develop safe and effective options for individuals with food allergies, allowing them and their loved ones to live worry-free.